System Transmission

Top Signal

100#1 JOB

Activity

2186Ripe

+960 today

System

Livenow

Terminal Asset View

stockNASDAQ

OZEM

$31.33-0.80%

ROUNDHILL GLP-1 & WEIGHT LOSS ETF

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

50Neutral

Live Analysis Active

Company Mission

This ETF provides a basket of stocks from companies that make weight-loss drugs, like those using GLP-1 technology. Investors buy shares to bet on the success of these treatments without owning each company individually. It makes money by charging management fees based on the total assets it holds, creating value through diversification and ease of access to a specialized market.

OZE

Industry Context

This asset operates in the exchange-traded fund (ETF) industry, which bundles various stocks into a single tradable security. It specifically targets the healthcare sector, focusing on companies involved in GLP-1 and weight-loss therapies, a niche with high growth potential due to rising obesity rates and medical advancements.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

39Matrix

Market Momentum

28.7— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.0x— Normal Volume

Today's Change

-0.80%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing OZEM across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 10:51 PM UTC

As-of As of 2026-03-15T22:36:13.815Z UTC (~15m delay).

Creates a specialized investment fund that pools money to buy stocks in companies developing Weight-Loss drugs, earning fees from investors who want targeted exposure to this growing medical trend.

Weekly range is narrowing near $25, often a precursor to a significant breakout or breakdown. Watch for price breaking above or below this level to confirm direction.

No technical indicators are available, but monitoring industry trends like FDA approvals for new Weight-Loss treatments can signal momentum. Watch for news affecting pharmaceutical stocks.

Volume data is unavailable, but observing market dynamics such as investor interest in healthcare ETFs during earnings seasons may indicate shifts. Monitor sector performance for clues.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...